Cart
sales@molnova.com
SRT 1720
CAS No. 925434-55-5
SRT 1720( SRT-1720 | SRT1720 )
Catalog No. M16631 CAS No. 925434-55-5
A potent, selective SIRT1 activator with EC1.5 of 0.16 uM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 30 | In Stock |
|
| 5MG | 48 | In Stock |
|
| 10MG | 76 | In Stock |
|
| 25MG | 151 | In Stock |
|
| 50MG | 290 | In Stock |
|
| 100MG | 412 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSRT 1720
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, selective SIRT1 activator with EC1.5 of 0.16 uM.
-
DescriptionA potent, selective SIRT1 activator with EC1.5 of 0.16 uM; displays good selectivity for activation of SIRT1 versus SIRT2 (EC1.5=37 uM) and SIRT3 (EC1.5>300 uM); 1,000-fold more potent than resveratrol; improve insulin sensitivity, lower plasma glucose, and increase mitochondrial capacity in obese mice model.
-
In Vitro——
-
In Vivo——
-
SynonymsSRT-1720 | SRT1720
-
PathwayChromatin/Epigenetic
-
TargetSirtuin
-
RecptorSIRT1|SIRT2
-
Research AreaMetabolic Disease
-
Indication——
Chemical Information
-
CAS Number925434-55-5
-
Formula Weight469.5614
-
Molecular FormulaC25H23N7OS
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESC1CN(CCN1)CC2=CSC3=NC(=CN23)C4=CC=CC=C4NC(=O)C5=NC6=CC=CC=C6N=C5
-
Chemical Name2-Quinoxalinecarboxamide, N-[2-[3-(1-piperazinylmethyl)imidazo[2,1-b]thiazol-6-yl]phenyl]-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Milne JC, et al. Nature. 2007 Nov 29;450(7170):712-6.
2. Pacholec M, et al. J Biol Chem. 2010 Mar 12;285(11):8340-51.
3. Funk JA, et al. J Pharmacol Exp Ther. 2010 May;333(2):593-601.
molnova catalog
related products
-
E1231
E1231 (E-1231) is a small molecule SIRT1 activator with EC50 of 0.83 uM.
-
BML-278
BML-278 is a SIRT1 activator with an EC150 of 1 μM. It increases H3K9 methylation and inhibits H3K9 acetylation in parental and maternal prokaryotes, improving early embryonic development.
-
Nicotinamide ribosid...
Nicotinamide riboside increases NAD[+] levels and activates SIRT1 and SIRT3, culminating in enhanced oxidative metabolism and protection against high fat diet-induced metabolic abnormalities.
